Related Experiment Videos

Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome

L M Cuadrado1, A Guerrero, J A Garcia Asenjo

  • 1Department of Internal Medicine, Hospital Clinico de San Carlos, Madrid.

Archives of Neurology
|January 1, 1988
PubMed

Insights

Two patients with AIDS and cerebral mucormycosis experienced a rapid, fatal outcome despite early treatment. This rare fungal infection, mucormycosis, should be considered in AIDS patients with central nervous system infections.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neurology

Background:

  • Acquired immunodeficiency syndrome (AIDS) compromises the immune system, increasing susceptibility to opportunistic infections.
  • Mucormycosis is a rare but severe fungal infection, typically affecting immunocompromised individuals.
  • Central nervous system (CNS) involvement in mucormycosis is uncommon but carries a high mortality rate.

Observation:

  • This report details two cases of isolated cerebral mucormycosis in patients with AIDS.
  • Both patients presented with a rapidly progressing and fatal clinical course.
  • Despite early diagnosis and treatment with amphotericin B, the outcome was universally fatal.

Findings:

  • Isolated cerebral mucormycosis is a previously unreported manifestation in patients with AIDS.
  • The aggressive nature of this infection in the described cases highlights its severity.
  • Standard treatment protocols may be insufficient to overcome the rapid progression of cerebral mucormycosis in this population.

Implications:

  • Mucormycosis must be considered in the differential diagnosis of CNS infections among individuals with AIDS, particularly intravenous drug users.
  • Prompt diagnosis, likely requiring brain biopsy, is crucial for identifying this devastating infection.
  • Further research is needed to understand the specific pathogenesis and develop effective therapeutic strategies for cerebral mucormycosis in AIDS patients.

Related Concept Videos